Filter
425
Text search:
vials
Featured
Recommendations
68
New Publications
111
Language
Document type
No document type
192
Guidelines
103
Manuals
39
Studies & Reports
38
Fact sheets
18
Training Material
11
Infographics
10
Strategic & Response Plan
9
Situation Updates
3
Brochures
1
Resource Platforms
1
Countries / Regions
India
51
Kenya
13
Global
12
South Africa
11
Nigeria
9
Ethiopia
9
Uganda
8
Philippines
8
Nepal
8
Zambia
8
Sierra Leone
6
Rwanda
6
Liberia
5
Ghana
5
Tanzania
5
Malawi
5
Congo, Democratic Republic of
4
Pakistan
4
Syria
4
Africa
4
Zimbabwe
3
Middle East and North Africa
3
Latin America and the Carribbean
3
Haiti
2
Lebanon
2
Sudan
2
Namibia
2
Madagascar
2
East and Southern Africa
2
West and Central Africa
2
Western and Central Europe
2
Morocco
1
Saudi Arabia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Cambodia
1
Indonesia
1
Bangladesh
1
Central African Republic
1
Ukraine
1
Greece
1
Libya
1
Angola
1
Myanmar / Burma
1
Yemen
1
South–East Asia Region
1
Asia
1
Bhutan
1
Eastern Europe
1
Albania
1
Russia
1
Iran
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
157
Clinical Guidelines
72
Key Resources
30
Women & Child Health
22
Public Health
18
Pharmacy & Technologies
14
Capacity Building
9
Toolboxes
COVID-19
59
Pharmacy
44
Ebola & Marburg
26
NTDs
25
Caregiver
20
TB
17
Polio
14
Rapid Response
14
AMR
13
HIV
10
Malaria
10
NCDs
6
Cholera
5
Conflict
5
Planetary Health
5
2.0 Rapid Response
5
Natural Hazards
4
Refugee
3
Mental Health
2
Disability
1
Zika
1
Specific Hazards
1
The "Integrated Management of Malaria Training – Health Worker’s Manual" is a practical guide developed by Uganda’s Ministry of Health to train healthcare workers at all levels in the effective diagnosis, treatment, prevention, and management of malaria. It aligns with national malaria treatme
...
Preferred product characteristics and clinical development considerations
Two malaria vaccines are currently WHO prequalified and recommended1 for use to prevent
P. falciparum malaria in young children, the RTS,S/AS01 vaccine, currently manufactured by
GlaxoSmithKline (GSK), and the R21/Matrix-M vaccine, manufactured by Serum Institute of India
Pvt (SII)
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands
...